What is it about?
Although newer basal insulin like glargine and degludec is most commonly used insulin currently, the real benefit about these drugs is hardly highlighted. This article critically analyse the pros and cons of all basal insulin starting from NPH to glargine to detemir to degludec. This article also compares glycaemic efficacy and hypoglycaemic outcomes between these basal insulin.
Featured Image
Why is it important?
Critical analysis of all existing basal insulin, in terms of glucose control, dose requirement and any hypoglycaemic outcome. Many untold stories explored in this article.
Read the Original
This page is a summary of: Modern basal insulin analogs: An incomplete story, Indian Journal of Endocrinology and Metabolism, January 2014, Medknow,
DOI: 10.4103/2230-8210.140239.
You can read the full text:
Resources
Contributors
The following have contributed to this page